184 related articles for article (PubMed ID: 10741630)
1. The interaction of diltiazem with simvastatin.
Mousa O; Brater DC; Sunblad KJ; Hall SD
Clin Pharmacol Ther; 2000 Mar; 67(3):267-74. PubMed ID: 10741630
[TBL] [Abstract][Full Text] [Related]
2. The interaction of diltiazem with lovastatin and pravastatin.
Azie NE; Brater DC; Becker PA; Jones DR; Hall SD
Clin Pharmacol Ther; 1998 Oct; 64(4):369-77. PubMed ID: 9797793
[TBL] [Abstract][Full Text] [Related]
3. Grapefruit juice-simvastatin interaction: effect on serum concentrations of simvastatin, simvastatin acid, and HMG-CoA reductase inhibitors.
Lilja JJ; Kivistö KT; Neuvonen PJ
Clin Pharmacol Ther; 1998 Nov; 64(5):477-83. PubMed ID: 9834039
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic and pharmacodynamic interactions between simvastatin and diltiazem in patients with hypercholesterolemia and hypertension.
Watanabe H; Kosuge K; Nishio S; Yamada H; Uchida S; Satoh H; Hayashi H; Ishizaki T; Ohashi K
Life Sci; 2004 Dec; 76(3):281-92. PubMed ID: 15531380
[TBL] [Abstract][Full Text] [Related]
5. Comparative pharmacokinetic interaction profiles of pravastatin, simvastatin, and atorvastatin when coadministered with cytochrome P450 inhibitors.
Jacobson TA
Am J Cardiol; 2004 Nov; 94(9):1140-6. PubMed ID: 15518608
[TBL] [Abstract][Full Text] [Related]
6. Interaction between amlodipine and simvastatin in patients with hypercholesterolemia and hypertension.
Nishio S; Watanabe H; Kosuge K; Uchida S; Hayashi H; Ohashi K
Hypertens Res; 2005 Mar; 28(3):223-7. PubMed ID: 16097365
[TBL] [Abstract][Full Text] [Related]
7. Grapefruit juice increases serum concentrations of atorvastatin and has no effect on pravastatin.
Lilja JJ; Kivistö KT; Neuvonen PJ
Clin Pharmacol Ther; 1999 Aug; 66(2):118-27. PubMed ID: 10460065
[TBL] [Abstract][Full Text] [Related]
8. Effect of polymorphic CYP3A5 genotype on the single-dose simvastatin pharmacokinetics in healthy subjects.
Kim KA; Park PW; Lee OJ; Kang DK; Park JY
J Clin Pharmacol; 2007 Jan; 47(1):87-93. PubMed ID: 17192506
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic interactions between nelfinavir and 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors atorvastatin and simvastatin.
Hsyu PH; Schultz-Smith MD; Lillibridge JH; Lewis RH; Kerr BM
Antimicrob Agents Chemother; 2001 Dec; 45(12):3445-50. PubMed ID: 11709322
[TBL] [Abstract][Full Text] [Related]
10. Rifampin greatly reduces plasma simvastatin and simvastatin acid concentrations.
Kyrklund C; Backman JT; Kivistö KT; Neuvonen M; Laitila J; Neuvonen PJ
Clin Pharmacol Ther; 2000 Dec; 68(6):592-7. PubMed ID: 11180018
[TBL] [Abstract][Full Text] [Related]
11. Simvastatin but not pravastatin is very susceptible to interaction with the CYP3A4 inhibitor itraconazole.
Neuvonen PJ; Kantola T; Kivistö KT
Clin Pharmacol Ther; 1998 Mar; 63(3):332-41. PubMed ID: 9542477
[TBL] [Abstract][Full Text] [Related]
12. Simvastatin-induced myopathy, the role of interaction with diltiazem and genetic predisposition.
Hu M; Mak VW; Tomlinson B
J Clin Pharm Ther; 2011 Jun; 36(3):419-25. PubMed ID: 21545622
[TBL] [Abstract][Full Text] [Related]
13. An open-label, crossover study of the pharmacokinetics of Insoluble Drug Delivery-MicroParticle fenofibrate in combination with atorvastatin, simvastatin, and extended-release niacin in healthy volunteers.
Penn R; Williams RX; Guha-Ray DK; Sawyers WG; Braun SL; Rains KT
Clin Ther; 2006 Jan; 28(1):45-54. PubMed ID: 16490579
[TBL] [Abstract][Full Text] [Related]
14. Duration of effect of grapefruit juice on the pharmacokinetics of the CYP3A4 substrate simvastatin.
Lilja JJ; Kivistö KT; Neuvonen PJ
Clin Pharmacol Ther; 2000 Oct; 68(4):384-90. PubMed ID: 11061578
[TBL] [Abstract][Full Text] [Related]
15. Studies to investigate the pharmacokinetic interactions between ranolazine and ketoconazole, diltiazem, or simvastatin during combined administration in healthy subjects.
Jerling M; Huan BL; Leung K; Chu N; Abdallah H; Hussein Z
J Clin Pharmacol; 2005 Apr; 45(4):422-33. PubMed ID: 15778423
[TBL] [Abstract][Full Text] [Related]
16. Simvastatin does not have a clinically significant pharmacokinetic interaction with fenofibrate in humans.
Bergman AJ; Murphy G; Burke J; Zhao JJ; Valesky R; Liu L; Lasseter KC; He W; Prueksaritanont T; Qiu Y; Hartford A; Vega JM; Paolini JF
J Clin Pharmacol; 2004 Sep; 44(9):1054-62. PubMed ID: 15317833
[TBL] [Abstract][Full Text] [Related]
17. Itraconazole alters the pharmacokinetics of atorvastatin to a greater extent than either cerivastatin or pravastatin.
Mazzu AL; Lasseter KC; Shamblen EC; Agarwal V; Lettieri J; Sundaresen P
Clin Pharmacol Ther; 2000 Oct; 68(4):391-400. PubMed ID: 11061579
[TBL] [Abstract][Full Text] [Related]
18. Diltiazem and mibefradil increase the plasma concentrations and greatly enhance the adrenal-suppressant effect of oral methylprednisolone.
Varis T; Backman JT; Kivistö KT; Neuvonen PJ
Clin Pharmacol Ther; 2000 Mar; 67(3):215-21. PubMed ID: 10741623
[TBL] [Abstract][Full Text] [Related]
19. Effect of oral ketoconazole on oral and intravenous pharmacokinetics of simvastatin and its acid in cynomolgus monkeys.
Ogasawara A; Utoh M; Nii K; Ueda A; Yoshikawa T; Kume T; Fukuzaki K
Drug Metab Dispos; 2009 Jan; 37(1):122-8. PubMed ID: 18854378
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of a pharmacokinetic interaction between valsartan and simvastatin in healthy subjects.
Sunkara G; Reynolds CV; Pommier F; Humbert H; Yeh C; Prasad P
Curr Med Res Opin; 2007 Mar; 23(3):631-40. PubMed ID: 17355744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
